Cancer treatment
Despite being informed about the risks and benefits of tamoxifen, a significant portion of high-risk women are unlikely to take the drug for breast cancer prevention. A study conducted by researchers at the University of Michigan Comprehensive Cancer Center found that only 6% of women said they were likely to
Cancer treatment
A study published in Cancer revealed that black women are less likely than white women to receive radiation therapy after a lumpectomy, a standard treatment for early stage breast cancer. The study, conducted by researchers at The University of Texas M. D. Anderson Cancer Center, examined Medicare records of over
Cancer research
Researchers at the University of Michigan Comprehensive Cancer Center have developed a decision aid to inform women about the risks and benefits of using tamoxifen for breast cancer prevention. The study targeted 632 women at high risk of developing breast cancer within the next five years, providing them with tailored
Cancer research
Circulating metastatic breast cancer cells can shed their epithelial receptors, a process that enables them to travel through the bloodstream undetected. Research presented at the CTRC-AACR San Antonio Breast Cancer Symposium suggested that these cells, known as epithelial-mesenchymal transition (EMT) cells, evade current detection methods and lose their traditional prognostic
Cancer treatment
A recent study has reported on the use of a nonreplicating adenoviral vector (Ad5) that contains the wild-type p53 transgene combined with chemotherapy as a novel gene-therapy approach for primary breast cancer. The study, led by M. Cristo-Fanilli and colleagues at the University of Texas, involved 13 patients with locally
Cancer treatment
Breast cancer progression is highly dependent on the growth and development of new blood vessels and lymphatic vessels, a process known as angiogenesis and lymphangiogenesis, respectively. Recent research has identified a key protein, hypoxia-inducible factor 1 alpha (HIF-1 alpha), as a crucial regulator of this process. HIF-1 alpha is a
Cancer research
Women with BRCA1 and BCRA2 mutations may be more susceptible to breast cancer from low-dose ionizing radiation, according to a study of 1600 women. The research found that those who underwent chest X-rays were 54% more likely to develop breast cancer. A significant increase in risk was observed in women
Cancer research
Researchers at the Ireland Cancer Center of University Hospitals of Cleveland have been awarded a significant grant to develop a novel optical device that enhances the accuracy of daily breast radiation therapy. The $250,000 grant, provided by the Susan G. Komen Breast Cancer Foundation, will support research into the
Cancer treatment
A recent study conducted by D. Fultonkehoe and colleagues at the University of Washington has found no significant association between the use of antidepressant medications and breast cancer risk. The study, published in the British Journal of Cancer in 2006, analyzed data from over 14,000 women enrolled in the
Cancer treatment
Recent studies from Belgium, Ireland, and the United States have made significant strides in breast cancer treatment, shedding light on the cost-effectiveness of Herceptin, a humanized monoclonal antibody, and the accuracy of Her2 protein expression measurement in breast carcinoma. Researchers have also explored the potential of combining lapatinib, a small
